Published in Clinical Oncology Week, August 11th, 2003
According to published research from Italy, "A case of cutaneous atypical fibroxanthoma (AFX) which metastasized, leading to patient death, is described.
"This is the third reported case in which a lesion qualified as AFX behaves in such an aggressive manner, comparable with that of malignant fibrous histiocytoma (MFH)," wrote C. Rizzardi and colleagues, University of Trieste.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.